Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 16/20 | 0.48 |
| ▸ | CA1 | P00915 | 15/20 | 0.46 |
| ▸ | MMP1 | P03956 | 5/20 | 0.46 |
| ▸ | MMP2 | P08253 | 5/20 | 0.46 |
| ▸ | MMP9 | P14780 | 5/20 | 0.46 |
| ▸ | MMP8 | P22894 | 5/20 | 0.46 |
| ▸ | MMP13 | P45452 | 5/20 | 0.46 |
| ▸ | F2 | P00734 | 4/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 4/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16444987 | 0.97 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL6396150 | 0.97 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL1146256 | 0.97 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL11806270 | 0.97 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL3960813 | 0.97 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL8108242 | 0.97 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL11802495 | 0.97 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL11810378 | 0.97 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL8437170 | 0.97 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL5078467 | 0.97 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120081755-A | Process for preparing 3- (4' -aminophenyl) -2-methoxypropionic acid and analogues and intermediates thereof | 诺格拉制药有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-113825739-B | Process for preparing 3- (4' -aminophenyl) -2-methoxypropionic acid and analogues and intermediates thereof | 诺格拉制药有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119661433-A | Photoacid generator, preparation method thereof and photoresist based on photoacid generator | 徐州博康信息化学品有限公司 | 2025-03-21 | — | — | CN | claimed |
| EP-4511372-A1 | PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB | Mirati Therapeutics, Inc. (US) | 2025-02-26 | — | — | EP | claimed |
| EP-4495101-A2 | PROCESS OF MAKING 3-(4'-AMINOPHENYL)-2-METHOXYPROPIONIC ACID, AND ANALOGS AND INTERMEDIATES THEREOF | Nogra Pharma Limited (IE) | 2025-01-22 | — | — | EP | claimed |
| US-20240409498-A1 | PROCESS OF MAKING 3-(4'-AMINOPHENYL)-2-METHOXYPROPIONIC ACID, AND ANALOGS AND INTERMEDIATES THEREOF | NOGRA PHARMA LIMITED (IE) | 2024-12-12 | — | — | US | claimed |
| CN-119072477-A | Process and intermediates for the synthesis of adaglazeb | 米拉蒂治疗股份有限公司 | 2024-12-03 | — | — | CN | claimed |
| EP-3921299-B1 | PROCESS OF MAKING 3-(4'-AMINOPHENYL)-2-METHOXYPROPIONIC ACID, AND ANALOGS AND INTERMEDIATES THEREOF | NOGRA PHARMA LTD (IE) | 2024-11-20 | — | — | EP | claimed |
| CN-111848832-B | Application of fluorine-containing compound modified cationic polymer as drug carrier and preparation method thereof | 苏州大学 | 2024-02-20 | — | — | CN | claimed |
| WO-2023205074-A1 | PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB | Mirati Therapeutics, Inc. (US) | 2023-10-26 | — | — | WO | claimed |
| US-20220194894-A1 | PROCESS OF MAKING 3-(4'-AMINOPHENYL)-2-METHOXYPROPIONIC ACID, AND ANALOGS AND INTERMEDIATES THEREOF | NOGRA PHARMA LIMITED (IE) | 2022-06-23 | — | — | US | claimed |
| CN-113825739-A | Process for preparing 3- (4' -aminophenyl) -2-methoxypropionic acid and analogs and intermediates thereof | 诺格拉制药有限公司 | 2021-12-21 | — | — | CN | claimed |
| CN-106458903-B | Method for producing heteroaromatic sulfonamide compound | 宇部兴产株式会社 | 2021-02-05 | — | — | CN | claimed |
| WO-2020132057-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ANHYDRIDE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION (US) | 2020-06-25 | — | — | WO | claimed |
| US-20200203711-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ANHYDRIDE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-06-25 | — | — | US | claimed |
| CN-110556509-A | Method for performing surface protection and passivation treatment on metallic lithium cathode by using fluorine-containing organic matter, product and application | NANJING UNIVERSITY OF TECHNOLOGY | 2019-12-10 | — | — | CN | claimed |
| EP-3156395-B1 | METHOD FOR PRODUCING HETEROAROMATIC SULFONAMIDE COMPOUND | UBE INDUSTRIES (JP) | 2019-01-09 | — | — | EP | claimed |
| US-20170121288-A1 | METHOD FOR PRODUCING HETEROAROMATIC SULFONAMIDE COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2017-05-04 | — | — | US | claimed |
| EP-3156395-A1 | METHOD FOR PRODUCING HETEROAROMATIC SULFONAMIDE COMPOUND | UBE Industries, Ltd. (JP) | 2017-04-19 | — | — | EP | claimed |
| US-5380789-A | Punching | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1995-01-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220194894-A1 | PROCESS OF MAKING 3-(4'-AMINOPHENYL)-2-METHOXYPROPIONIC ACID, AND ANALOGS AND INTERMEDIATES THEREOF | PPARA, PPARG, PPARD | CA2 4023/4885CA1 4808/4885MMP1 4783/4885 |
| US-20170121288-A1 | METHOD FOR PRODUCING HETEROAROMATIC SULFONAMIDE COMPOUND | PFAS, SULT2A1, ARSA | CA2 102/4885CA1 62/4885MMP1 3889/4885 |
| US-20240409498-A1 | PROCESS OF MAKING 3-(4'-AMINOPHENYL)-2-METHOXYPROPIONIC ACID, AND ANALOGS AND INTERMEDIATES THEREOF | PPARA, PPARG, PPARD | CA2 3836/4885CA1 4747/4885MMP1 4826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.